Department of Orthopedics Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi 755-8505, Japan.
Int J Mol Sci. 2023 Jan 28;24(3):2528. doi: 10.3390/ijms24032528.
Spinal cord injury (SCI) is a catastrophic condition associated with significant neurological deficit and social and financial burdens. It is currently being managed symptomatically, with no real therapeutic strategies available. In recent years, a number of innovative regenerative strategies have emerged and have been continuously investigated in preclinical research and clinical trials. In the near future, several more are expected to come down the translational pipeline. Among ongoing and completed trials are those reporting the use of biomaterial scaffolds. The advancements in biomaterial technology, combined with stem cell therapy or other regenerative therapy, can now accelerate the progress of promising novel therapeutic strategies from bench to bedside. Various types of approaches to regeneration therapy for SCI have been combined with the use of supportive biomaterial scaffolds as a drug and cell delivery system to facilitate favorable cell-material interactions and the supportive effect of neuroprotection. In this review, we summarize some of the most recent insights of preclinical and clinical studies using biomaterial scaffolds in regenerative therapy for SCI and summarized the biomaterial strategies for treatment with simplified results data. One hundred and sixty-eight articles were selected in the present review, in which we focused on biomaterial scaffolds. We conducted our search of articles using PubMed and Medline, a medical database. We used a combination of "Spinal cord injury" and ["Biomaterial", or "Scaffold"] as search terms and searched articles published up until 30 April 2022. Successful future therapies will require these biomaterial scaffolds and other synergistic approaches to address the persistent barriers to regeneration, including glial scarring, the loss of a structural framework, and biocompatibility. This database could serve as a benchmark to progress in future clinical trials for SCI using biomaterial scaffolds.
脊髓损伤 (SCI) 是一种与严重神经功能缺损以及社会和经济负担相关的灾难性疾病。目前,它只能通过对症治疗,并没有真正的治疗策略。近年来,出现了许多创新的再生策略,并在临床前研究和临床试验中不断得到研究。在不久的将来,预计会有更多的策略从转化管道中出现。正在进行和已完成的试验中,有一些报告了生物材料支架的使用。生物材料技术的进步,结合干细胞治疗或其他再生治疗,可以加速有前途的新型治疗策略从实验室到临床的进展。已经将各种类型的 SCI 再生治疗方法与使用支持性生物材料支架相结合,作为药物和细胞输送系统,以促进有利的细胞-材料相互作用和神经保护的支持作用。在这篇综述中,我们总结了一些最近在使用生物材料支架进行 SCI 再生治疗的临床前和临床研究中的最新见解,并总结了生物材料治疗策略,简化了结果数据。在本次综述中,我们共选择了 168 篇文章,重点关注生物材料支架。我们使用 PubMed 和 Medline 医学数据库进行了文章搜索。我们使用了“Spinal cord injury”和“Biomaterial”或“Scaffold”的组合作为搜索词,并搜索了截至 2022 年 4 月 30 日发表的文章。成功的未来疗法将需要这些生物材料支架和其他协同方法来解决持续的再生障碍,包括神经胶质瘢痕形成、结构框架丧失和生物相容性。这个数据库可以作为未来使用生物材料支架治疗 SCI 的临床试验进展的基准。